Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment

Inflammatory bowel disease (IBD) is a chronic condition that affects about 7 million people worldwide, and new therapies are needed. Understanding the complex roles that bile acids (BAs) play in IBD may lead to the development of novel IBD treatments independent of direct immunosuppression. This rev...

Full description

Saved in:
Bibliographic Details
Main Authors: Samantha H. Bai, Arun Chandnani, Siyan Cao
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/12/2910
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846105648081666048
author Samantha H. Bai
Arun Chandnani
Siyan Cao
author_facet Samantha H. Bai
Arun Chandnani
Siyan Cao
author_sort Samantha H. Bai
collection DOAJ
description Inflammatory bowel disease (IBD) is a chronic condition that affects about 7 million people worldwide, and new therapies are needed. Understanding the complex roles that bile acids (BAs) play in IBD may lead to the development of novel IBD treatments independent of direct immunosuppression. This review discusses the latest discoveries in the roles BAs play in IBD pathogenesis and explores how these discoveries offer promising new therapeutic targets to treat IBD and improve patient outcomes. Several therapies discussed include specific BA receptor (BAR) agonists, dietary therapies, supplements, probiotics, and mesenchymal stem cell therapies that have all been shown to decrease IBD disease activity.
format Article
id doaj-art-97c703382e664b7bba8d2269a1a5897d
institution Kabale University
issn 2227-9059
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-97c703382e664b7bba8d2269a1a5897d2024-12-27T14:13:14ZengMDPI AGBiomedicines2227-90592024-12-011212291010.3390/biomedicines12122910Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to TreatmentSamantha H. Bai0Arun Chandnani1Siyan Cao2Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USADivision of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USADivision of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAInflammatory bowel disease (IBD) is a chronic condition that affects about 7 million people worldwide, and new therapies are needed. Understanding the complex roles that bile acids (BAs) play in IBD may lead to the development of novel IBD treatments independent of direct immunosuppression. This review discusses the latest discoveries in the roles BAs play in IBD pathogenesis and explores how these discoveries offer promising new therapeutic targets to treat IBD and improve patient outcomes. Several therapies discussed include specific BA receptor (BAR) agonists, dietary therapies, supplements, probiotics, and mesenchymal stem cell therapies that have all been shown to decrease IBD disease activity.https://www.mdpi.com/2227-9059/12/12/2910bile acidsinflammatory bowel diseaseulcerative colitisCrohn’s diseasepathogenesisnew therapies
spellingShingle Samantha H. Bai
Arun Chandnani
Siyan Cao
Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
Biomedicines
bile acids
inflammatory bowel disease
ulcerative colitis
Crohn’s disease
pathogenesis
new therapies
title Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
title_full Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
title_fullStr Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
title_full_unstemmed Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
title_short Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
title_sort bile acids in inflammatory bowel disease from pathophysiology to treatment
topic bile acids
inflammatory bowel disease
ulcerative colitis
Crohn’s disease
pathogenesis
new therapies
url https://www.mdpi.com/2227-9059/12/12/2910
work_keys_str_mv AT samanthahbai bileacidsininflammatoryboweldiseasefrompathophysiologytotreatment
AT arunchandnani bileacidsininflammatoryboweldiseasefrompathophysiologytotreatment
AT siyancao bileacidsininflammatoryboweldiseasefrompathophysiologytotreatment